Brevan Howard Capital Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
37,670
+1,768
+5% +$49.2K 0.01% 1016
2026
Q1
$671K Buy
+35,902
New +$685K 0.01% 1125
2025
Q3
– Sell
-21,885
Closed -$367K – 2270
2025
Q2
$367K Buy
+21,885
New +$386K ﹤0.01% 1477
2024
Q4
– Sell
-16,154
Closed -$600K – 1410
2024
Q3
$600K Buy
+16,154
New +$602K ﹤0.01% 633

Other funds holding STAA

Brevan Howard Capital Management's STAA Position: Q2 2026 in Review

Brevan Howard Capital Management increased its STAAR Surgical (STAA) stake by 4.9% in Q2 2026, buying an estimated $49.2K and bringing the position to 37,670 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #1016.

Brevan Howard Capital Management first reported a position in STAA in Q3 2024 and has held it in 4 quarters since. 201 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Brevan Howard Capital Management held 37,670 shares of STAAR Surgical worth $1.08M as of Q2 2026.
  • Brevan Howard Capital Management bought 1,768 STAAR Surgical shares in Q2 2026, an estimated $49.2K.
  • STAAR Surgical made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1016 holding.
  • Brevan Howard Capital Management first reported a position in STAAR Surgical in Q3 2024 and has held it in 4 quarters since.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.